Cargando…

Safety and Efficacy of Apixaban vs Warfarin in Patients With Stage 4 and 5 Chronic Kidney Disease: A Systematic Review

Warfarin has been an anticoagulant of choice in patients with advanced Chronic Kidney Diseases (CKD) at stages 4 and 5 for decades, but with the advent of Novel Oral Anticoagulants (NOACs), there has been a sharp rise in their prescriptions. Among all NOACS, apixaban is the least reliant on kidney f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fatima, Hameeda, Nwankwo, Ijeoma, Anam, Mahvish, Maharjan, Shrinkhala, Amjad, Zainab, Abaza, Abdelrahman, Vasavada, Advait M, Sadhu, Akhil, Valencia, Carla, Khan, Safeera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651588/ https://www.ncbi.nlm.nih.gov/pubmed/36381830 http://dx.doi.org/10.7759/cureus.30230

Ejemplares similares

A Systematic Review of Apoptosis in Correlation With Cancer: Should Apoptosis Be the Ultimate Target for Cancer Treatment?
por: Abaza, Abdelrahman, et al.
Publicado: (2022)

Haloperidol Versus Atypical Antipsychotics for Treating Delirium in Intensive Care Unit Patients: A Systematic Review
por: Sadhu, Akhil, et al.
Publicado: (2022)

A Correlation Between the Pathogenic Processes of Fibromyalgia and Irritable Bowel Syndrome in the Middle-Aged Population: A Systematic Review
por: Valencia, Carla, et al.
Publicado: (2022)

Efficacy of Semaglutide in Treating Obesity: A Systematic Review of Randomized Controlled Trials (RCTs)
por: Anam, Mahvish, et al.
Publicado: (2022)

Executive Dysfunction in Patients With Alcohol Use Disorder: A Systematic Review
por: Maharjan, Shrinkhala, et al.
Publicado: (2022)

Inhaled Antibiotics in Non-cystic Fibrosis Bronchiectasis (NCFB): A Systematic Review of Efficacy and Limitations in Adult Patients
por: Amjad, Zainab, et al.
Publicado: (2022)

Comparing the Efficacy and Safety of Apixaban Versus Warfarin in Morbidly Obese Patients
por: Alotaibi, Sultan N, et al.
Publicado: (2022)

Apixaban-Induced Hepatotoxicity
por: Ansari, Umair, et al.
Publicado: (2022)

Major bleeding risk among non‐valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a “real‐world” observational study in the United States
por: Lip, Gregory Y. H., et al.
Publicado: (2016)

Venous Thromboembolism While on Anticoagulation With Apixaban
por: Mazahreh, Farah, et al.
Publicado: (2021)

Apixaban-Induced Pseudo-Ludwig’s Angina
por: Figaro, Nicholas, et al.
Publicado: (2022)

Delayed Vesicular Urticarial Dermatosis Due to Apixaban
por: Garzon-Siatoya, Wendy T, et al.
Publicado: (2021)

Apixaban vs. Warfarin in Atrial Fibrillation Patients With Chronic Kidney Disease
por: Fu, Chung-Ming, et al.
Publicado: (2021)

Renal Vein Thrombosis Treated With Apixaban in a Patient With COVID-19: A Case Report
por: Kakhktsyan, Tigran, et al.
Publicado: (2023)

Clinically Ambiguous Hemorrhagic Cardiac Tamponade Associated with Apixaban
por: Aguilar-Gallardo, Jose S, et al.
Publicado: (2022)

Adrenal Hemorrhage in a Patient Anticoagulated with Apixaban with Antiphospholipid Syndrome
por: Sanford, Zachary, et al.
Publicado: (2019)

Hemorrhagic Pericardial Effusion From Apixaban Use: Case Report and Literature Review
por: Nasir, Syed Alishan, et al.
Publicado: (2022)

Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity
por: Cohen, Alexander, et al.
Publicado: (2021)

A Case of Limb-Threatening Hematoma in a Patient Taking Citalopram and Apixaban Concurrently
por: Datta, Sorabh, et al.
Publicado: (2021)

Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding
por: Cohen, Alexander T., et al.
Publicado: (2022)

Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences
por: Cohen, Alexander T., et al.
Publicado: (2023)

Obesity and Atrial Fibrillation: Should We Screen for Atrial Fibrillation in Obese Individuals? A Comprehensive Review
por: Ghattas, Kyrillos N, et al.
Publicado: (2020)

The Role of Warfarin and Rivaroxaban in the Treatment of Cerebral Venous Thrombosis
por: Fayyaz, Muniba, et al.
Publicado: (2019)

Warfarin Dosing Requirement According to Body Mass Index
por: Alshammari, Abdullah, et al.
Publicado: (2020)

A case of apixaban-associated idiopathic interstitial pneumonia
por: Yun, Won-Sik, et al.
Publicado: (2022)

Safety and effectiveness of apixaban compared to warfarin in dialysis patients
por: Reed, Daniel, et al.
Publicado: (2018)

Apixaban/heparin/warfarin: Treatment failure: case report
Publicado: (2021)

Dual Anticoagulation With Warfarin and Apixaban: A Case Report
por: Parker, Kristen, et al.
Publicado: (2022)

Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Heart Failure: An Umbrella Review
por: Roy, Raj, et al.
Publicado: (2023)

Choices and Challenges With Drug Therapy in Postural Orthostatic Tachycardia Syndrome: A Systematic Review
por: Vasavada, Advait M, et al.
Publicado: (2023)

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
por: Christersson, Christina, et al.
Publicado: (2019)

A comparison between warfarin and apixaban: A patient's perspective
por: Althemery, Abdullah U., et al.
Publicado: (2020)

Safety of apixaban and rivaroxaban compared to warfarin after cardiac surgery
por: Naik, Kushal D., et al.
Publicado: (2022)

Carotid Endarterectomy Versus Stenting for the Treatment of Patients With Carotid Artery Stenosis: An Updated Systematic Review and Meta-Analysis
por: Vasavada, Advait M, et al.
Publicado: (2023)

The Effect of Percutaneous Coronary Intervention on QT Dispersion and the Association Between Them: A Systematic Review
por: Dahrab, Mahdi, et al.
Publicado: (2023)

Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study
por: Wanat, Matthew A., et al.
Publicado: (2019)

Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation
por: Lee, Soyon, et al.
Publicado: (2012)

Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
por: Bahit, M Cecilia, et al.
Publicado: (2017)

Unusual Presentation of Acute Perimyocarditis Following SARS-COV-2 mRNA-1237 Moderna Vaccination
por: Khogali, Fatima, et al.
Publicado: (2021)

Effectiveness of Catheter Ablation in Left Ventricular Ejection Fraction, Stroke, Quality of Life, All-Cause Mortality, Sinus Rhythm Maintenance, and Hospitalization Rates as Compared to Medical Therapy
por: Oble, Mrinal J P, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f5ali3l0mj37c4bs3da26genkq